| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |